SION

Cloonan Michael

Known title: President & CEOCIK: 0001704336

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 16, 2026

Sionna Shares Fall 37.6% Over 4 Weeks, Trend Reversal Possible. Sionna Therapeutics shares fell 37.6% over the past four weeks. The drop has pushed the stock into a low RSI zone of 23.4, suggesting it may be oversold. The price is near a key support level at $5.71, which has been tested 20 times. Analysts see a potential trend reversal, but the stock remains far below its 52‑week high of $54.97.

this person other insiders at SION

Transaction History

SION▲ Buy$0
SION▲ Buy$0
SION▲ Buy$81K
SION▼ Sell$459K
SION▲ Buy$184K
SION▼ Sell$1.1M
SION▲ Buy$140K
SION▼ Sell$838K
SION▲ Buy$205K
SION▼ Sell$1.3M
SION▼ Sell$7K
SION▲ Buy$62K
SION▼ Sell$322K
SION▲ Buy$1K
SION▲ Buy$90K
SION▼ Sell$460K
SION▲ Buy$48K
SION▼ Sell$231K
SION▼ Sell$496K
SION▲ Buy$105K
SION▲ Buy$45K
SION▼ Sell$186K
SION▲ Buy$107K
SION▼ Sell$439K
SION▲ Buy$153K
SION▼ Sell$569K

We use analytics to understand how market-wall is used. No personal data is sold.